Indrayani Biotech Limited

Indrayani Biotech Limited

INDRANIB.BO
Indrayani Biotech LimitedIN flagBombay Stock Exchange
8.01
INR
-0.35
- -
364.75MMarket Cap
Indrayani Biotech Limited
INDRANIB.BO
(Bombay Stock Exchange)

Recent

price

8.01

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
159.11
- -
- -
- -
- -
- -
- -
137.2
5.92
17.99
47.6
45.81
28.6
31.55
Revenue per Share
- -
-0.18
-0.19
-0.28
-0.35
-0.28
-0.34
-0.15
2.22
-3.15
1.3
2.55
2.87
-1.34
-1.31
Basic EPS, GAAP
- -
4.41
-0.18
-0.25
-0.37
-0.28
-0.32
-0.58
6.8
-0.12
0.85
-7.95
-12.86
-1.78
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
9.65
9.21
8.93
-1.02
-1.29
-1.65
-1.82
84.79
5.54
7.06
12.31
13.9
10.72
- -
Book Value per Share
- -
-5.58
-0.39
-0.67
-1.02
-1.29
-1.65
-1.82
74.25
4.56
6.06
7.3
14.58
16.81
- -
Tangible Book Value per Share
- -
4
4
4
4
4
4
4
4
36
34
34
36
46
48
Basic Weighted Avg Shares
393
580
- -
- -
- -
- -
- -
- -
499
211
616
1,629
1,662
1,302
1,506
Sales/Revenue/Turnover
1.58
1
- -
- -
- -
- -
- -
- -
3.53
-23.29
9.95
8.58
11.94
3.09
0.9
Operating Margin (%)
3
3
- -
- -
- -
- -
- -
- -
10
5
7
33
38
34
15
Depreciation Expense
- -
-1
-1
-1
-1
-1
-1
-1
8
-112
44
87
104
-61
-63
Net Income, GAAP
144.66
350.43
- -
- -
- -
- -
- -
- -
- -
- -
0.28
3.05
5.03
- -
57.94
Effective Tax Rate (%)
-0.12
-0.11
- -
- -
- -
- -
- -
- -
1.62
-53.18
7.21
5.36
6.27
-4.69
-4.16
Profit Margin (%)
-21
-19
- -
- -
- -
- -
- -
- -
55
-27
1
56
579
755
- -
Working Capital
- -
- -
1
3
4
5
6
6
69
82
73
357
707
654
- -
LT Debt
36
35
34
33
-4
-5
-6
-7
308
201
246
484
763
999
- -
Total Equity
- -
-26.2
- -
- -
- -
- -
- -
- -
7.91
- -
15.47
16.73
12.27
- -
- -
Return on Invested Capital (%)
- -
-15.55
- -
- -
- -
- -
- -
- -
8.79
- -
15.86
13.95
11.35
- -
12.36
Return on Capital (%)
- -
-1.83
-2.03
-3.06
- -
- -
- -
- -
- -
-44.37
20.24
26.36
22.52
-12.31
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Jun'26
Sep'26
Dec'26
ST Debt
- -
454
- -
LT Borrowings
- -
1,009
- -
LT Finance Leases
- -
-1
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
46
- -
Market Capitalization
672
599
540

Working Capital

FRC

in mil. unless spec.
Jun'26
Sep'26
Dec'26
Total Current Assets
- -
1,839
- -
Cash, Cash Equivalents & STI
- -
70
- -
Accounts Receivable, Net
- -
623
- -
Inventories
- -
432
- -
Total Current Liabilities
- -
696
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
454
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-468.19%
34.6%
30.98%
Free Cash Flow
-310.15%
-385.42%
-82.6%
Net Income, GAAP
-329.72%
-334.23%
-158.6%
Sales/Revenue/Turnover
- -
55.84%
-21.66%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
423
404
391
444
1,662
2025
315
308
173
506
1,302
2026
291
359
350
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.13
1.62
0.22
- -
2.87
2025
0.19
0.27
0.05
- -
-1.34
2026
0.03
0.2
0.01
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Indrayani Biotech Limited operates across diverse sectors, including food and hospitality, dairy, healthcare, pharmaceuticals, engineering, biotechnology, agriculture, and infrastructure. The company strategically grows by acquiring and partnering with established small and medium-sized enterprises across India. Its primary operational divisions encompass Foods and Hospitality, which offers contract food supply services to various institutions; Engineering, covering power electronics and boiler manufacturing; and Healthcare, involving hospitals, clinics, and pharmaceutical operations. Additionally, the company is active in the production of bio-fertilizers and bio-pest controllers through its biotech unit, corporate farming, and the promotion of commercial and residential infrastructure projects. Established on March 9, 1992, the company maintains its headquarters in Chennai, India.